FIELD: medicine. SUBSTANCE: method involves administering pharmaceutical composition containing 5- aminolevulinic acid or its derivatives and exposing the organism to light in performing photodynamic therapy. EFFECT: combined antitumor therapy and immune status correction; enhanced effectiveness of treatment. 5 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR APPLYING PHOTODYNAMIC THERAPY IN TREATING PATIENTS HAVING MALIGNANT TUMORS | 1999 |
|
RU2161053C1 |
PHOTODYNAMIC THERAPY METHOD FOR TREATING MALIGNANT ESOPHAGUS STRICTURE CASES | 2004 |
|
RU2267338C1 |
FLUORESCENT METHOD FOR DIAGNOSING MALIGNANT TUMOR LESIONS OF PLEURAL AND ABDOMINAL CAVITY ORGANS | 2002 |
|
RU2232038C1 |
COMPOSITION FOR FLUORESCENT DIAGNOSTICS AND PHOTODYNAMIC THERAPY | 2008 |
|
RU2379026C2 |
METHOD OF TREATMENT OF SUPERFICIAL BLADDER CANCER | 2007 |
|
RU2346657C1 |
METHOD OF PHOTODYNAMIC THERAPY OF ONCOLOGICAL DISEASES | 2004 |
|
RU2290972C2 |
METHOD FOR TREATING ATYPICAL ENDOMETRIUM HYPERPLASIA | 2002 |
|
RU2212202C1 |
METHOD OF ORGAN-PRESERVING TREATMENT OF PATIENTS WITH INITIAL CARCINOMA OF VULVA | 2010 |
|
RU2445991C2 |
METHOD FOR IDENTIFICATION OF OPTIMAL MODES OF FLUORESCENT DIAGNOSTICS AND PHOTODYNAMIC THERAPY | 2008 |
|
RU2376044C1 |
METHOD FOR ULTRASONIC INTRAOPERATIVE INTRACAVITARY CHEMOTHERAPY | 1999 |
|
RU2162721C2 |
Authors
Dates
2000-12-20—Published
1999-10-12—Filed